<DOC>
	<DOCNO>NCT00738088</DOCNO>
	<brief_summary>The study hypothesis people respond well sulphonylureas different underlie cause diabetes people respond poorly medication . We use two approach study . In one approach look people previously respond well poorly , confirm rechallenging sulphonylurea drug , look well produce insulin response glucose intravenous sulphonylurea call tolbutamide . The second approach identifies people certain genetic predisposition diabetes ( due change TCF7L2 gene ) look well respond sulphonylurea medication .</brief_summary>
	<brief_title>Variation Sulphonylurea Response Type 2 Diabetes</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Gliclazide</mesh_term>
	<criteria>Type 2 diabetes Age &gt; 35 &lt; 70 Age diabetes diagnosis &gt; 35 &lt; 70 White European PreSU HbA1c &lt; =10 % HbA1c ( treatment ) &lt; = 9 % No myocardial infarction Acute coronary syndrome previous year No stroke transient ischaemic attack previous year No stable ( background ) retinopathy ( unscheduled laser treatment last 6 month ) eGFR &gt; 60mls/min No Proteinuria &gt; 30mg/dl multistix 10SG No active foot ulceration infection Liver ALT â‰¤ twice upper limit reference range Contactable telephone Type 1 diabetes HbA1c &gt; 10 % prior commence SU HbA1c &gt; 9 % SU treatment Recent MI Stroke within last 12 month Preproliferative proliferative retinopathy eGFR &lt; 60 ml/min Proteinuria &gt; 30mg/dl multistix 10SG Active foot ulceration infection Liver ALT &gt; twice upper limit reference range Female planning conceive within study period Any significant medical reason exclusion determine investigator</criteria>
	<gender>All</gender>
	<minimum_age>35 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>August 2008</verification_date>
	<keyword>Sulphonylurea</keyword>
	<keyword>Pharmacogenetics</keyword>
</DOC>